Delos Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Delos Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $14,993 - $16,765	-259 Reduced 1.37%	18,708 $1.09 Million
Q2 2023 Sep 01, 2023	SELL	$63.71 - $70.74 $85,371 - $94,791	-1,340 Reduced 6.6%	18,967 $1.21 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $516,349 - $585,656	-7,858 Reduced 27.9%	20,307 $1.41 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $13,832 - $16,380	202 Added 0.72%	28,165 $2.03 Million
Q3 2022 Nov 15, 2022	BUY	$0.13 - $76.84 $531 - $313,968	4,086 Added 17.11%	27,963 $1.99 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $836,509 - $921,289	11,519 Added 93.21%	23,877 $1.84 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $759,769 - $911,031	12,358 New	12,358 $903,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $5,363 - $6,252	-100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5,917 - $6,931	100 New	100 $6,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Delos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Delos Wealth Advisors, LLC with notifications on news.